内科重症监护病房血流感染患者死亡的危险因素
该回顾性病例对照研究纳入2015年1月至2023年12月中南大学湘雅三医院内科ICU的106例血流感染成人患者,分析其临床特征及3个月全因死亡危险因素。结果示血流感染发生率为2.2%,3个月全因死亡率为64.2%,革兰阴性菌占64.6%,以肺炎克雷伯菌最常见(25.7%)。多因素Logistic回归显示起病时淋巴细胞≤0.5×10⁹/L(OR=3.268)、脓毒性休克(OR=3.637)和需要机械通气(OR=4.111)是独立危险因素,恰当经验性抗生素治疗为保护因素(OR=0.316)。
要点
- 内科ICU血流感染患者3个月全因死亡率为64.2%(68/106),革兰阴性菌占64.6%,肺炎克雷伯菌最常见(29株,25.7%)。
- 起病时淋巴细胞≤0.5×10⁹/L是3个月全因死亡的独立危险因素(OR=3.268,95%CI 1.196-8.927,P=0.021)。
- 起病时脓毒性休克是独立危险因素(OR=3.637,95%CI 1.293-10.235,P=0.014)。
- 需要机械通气是独立危险因素(OR=4.111,95%CI 1.242-13.610,P=0.021)。
- 起病后接受恰当经验性抗生素治疗是保护因素(OR=0.316,95%CI 0.118-0.844,P=0.022)。
适用人群与场景
- 2015年1月至2023年12月中南大学湘雅三医院内科ICU收治的成人血流感染患者,共106例。
- 血流感染发生率为2.2%(106/4820例内科ICU患者)。
- 最常见伴随诊断为肺部感染(99例,93.4%),常见合并症包括2型糖尿病(39例,36.8%)、消化道出血(26例,24.5%)、恶性肿瘤(23例,21.7%)和慢性阻塞性肺疾病(21例,19.8%)。
- 血流感染最常见来源为肺(53例,50.0%)。
处置流程与药物剂量
- 起病后40例(37.7%)接受恰当经验性抗生素治疗。
- 83例(78.3%)需要机械通气,26例(24.5%)需要肾脏替代治疗。
红旗征与不能漏的情况
- 起病时存在脓毒性休克(71例,67.0%)为独立危险因素(OR=3.637,95%CI 1.293-10.235,P=0.014)。
- 起病时淋巴细胞≤0.5×10⁹/L为独立危险因素(OR=3.268,95%CI 1.196-8.927,P=0.021)。
- 需要机械通气为独立危险因素(OR=4.111,95%CI 1.242-13.610,P=0.021)。
研究设计与关键结果
- 研究类型为回顾性病例对照研究,纳入106例内科ICU血流感染成人患者,按3个月随访结局分为存活组(38例,35.8%)和死亡组(68例,64.2%)。
- 共分离出113株细菌或真菌,革兰阴性菌73株(64.6%),以肠杆菌科为主,肺炎克雷伯菌29株(25.7%)。
- 单因素分析显示死亡组年龄≥75岁、恶性肿瘤、碳青霉烯耐药革兰阴性菌血流感染、起病时淋巴细胞≤0.5×10⁹/L、起病时脓毒性休克、需要机械通气和肾脏替代治疗的比例显著高于存活组,而BMI>23 kg/m²和接受恰当经验性抗生素治疗的比例显著低于存活组(均P<0.05)。
- 多因素Logistic回归显示起病时淋巴细胞≤0.5×10⁹/L(OR=3.268,95%CI 1.196-8.927,P=0.021)、起病时脓毒性休克(OR=3.637,95%CI 1.293-10.235,P=0.014)和需要机械通气(OR=4.111,95%CI 1.242-13.610,P=0.021)是3个月全因死亡的独立危险因素;接受恰当经验性抗生素治疗为保护因素(OR=0.316,95%CI 0.118-0.844,P=0.022)。
- Hosmer-Lemeshow检验χ²=5.082,自由度6,P=0.533,提示模型无过拟合证据。
- 血流感染后中位内科ICU住院时间和中位总住院时间分别为10.0(4.0,20.3)天和16.0(7.0,28.3)天。
证据类型、等级与局限
- 证据类型:回顾性病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对内科ICU血流感染患者,起病时淋巴细胞≤0.5×10⁹/L、脓毒性休克和需要机械通气提示3个月全因死亡风险更高。
- 起病后接受恰当经验性抗生素治疗与3个月全因死亡风险降低相关(OR=0.316,95%CI 0.118-0.844,P=0.022)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the incidence, etiological characteristics, and risk factors for death in patients with bloodstream infection in a medical intensive care unit (ICU).
METHODS: A retrospective case-control study was conducted. Adult patients with bloodstream infection admitted to the medical ICU of The Third Xiangya Hospital of Central South University from January 2015 to December 2023 were enrolled. Data were collected from the hospital's electronic medical record system, including demographic characteristics [gender, age, body mass index (BMI)], clinical features (comorbidities, pathogen types, source of bloodstream infection, antibiotic use), laboratory parameters [routine blood test, liver and kidney function, results of bacterial culture and drug susceptibility test, C-reactive protein (CRP), procalcitonin (PCT), etc.], clinical management (red blood cell transfusion and usage of immunoglobulin, thymosin α1, glucocorticoid, empirical antibiotic therapy, mechanical ventilation, renal replacement therapy, etc.), and prognostic indicators (length of medical ICU stay and length of hospital stay after bloodstream infection). All patients were followed up for at least 3 months after the onset of bloodstream infection. Based on follow-up outcomes, patients were divided into survivor and non-survivor groups. Univariate analysis was used to identify variables associated with 3-month all-cause death in patients with bloodstream infection. Variables with P<0.05 in the univariate analysis were entered into multivariate Logistic regression analysis to identify independent risk factors for 3-month all-cause death. The Hosmer-Lemeshow test was used to assess the goodness-of-fit of the regression model.
RESULTS: A total of 106 of the 4 820 medical ICU patients (2.2%) ultimately included in the study developed bloodstream infection during the 9 years. Among the 106 patients with bloodstream infection, the majority were male (71 cases, 67.0%), with an advanced age [(64.2±17.1) years]. The BMI was 23.0 (21.0, 23.0) kg/m2. The most common concomitant diagnosis was pulmonary infection (99 cases, 93.4%). Common comorbidities included type 2 diabetes mellitus (39 cases, 36.8%), gastrointestinal bleeding (26 cases, 24.5%), malignancy (23 cases, 21.7%), and chronic obstructive pulmonary disease (21 cases, 19.8%). The most common source of bloodstream infection was the lung (53 cases, 50.0%). At the time of bloodstream infection onset, patients presented with a clinical state characterized by immunosuppression, systemic inflammatory response, malnutrition and potential kidney injury. Septic shock was present at the time of bloodstream infection onset in 71 patients (67.0%). Forty patients (37.7%) received appropriate empirical antibiotic therapy after bloodstream infection onset. Mechanical ventilation was required in 83 patients (78.3%), and renal replacement therapy was required in 26 patients (24.5%). The median length of medical ICU stay and the median total hospital stay after bloodstream infection were 10.0 (4.0, 20.3) days and 16.0 (7.0, 28.3) days, respectively. A total of 113 bacterial or fungal strains were isolated from the blood of the 106 patients with bloodstream infection, among which Gram-negative bacteria were the predominant pathogens (73 strains, 64.6%). The most common pathogens were Enterobacteriaceae, predominantly Klebsiella pneumoniae (29 strains, 25.7%). Among the 106 patients, 68 patients (64.2%) died within 3 months after bloodstream infection onset, while 38 patients (35.8%) survived. Univariate analysis showed that, compared with the survivor group, the non-survivor group had significantly higher proportions of patients aged≥75 years, those with malignancy, those with carbapenem-resistant Gram-negative bacterial bloodstream infection, those with LYM≤0.5×109/L at bloodstream infection onset, those with septic shock at bloodstream infection onset, those requiring mechanical ventilation and renal replacement therapy. In contrast, the proportions of patients with BMI>23 kg/m2 and those receiving appropriate empirical antibiotic therapy after bloodstream infection onset were significantly lower in the non-survivor group (all P<0.05). Multivariate Logistic regression analysis showed that LYM≤0.5×109/L at bloodstream infection onset [odds ratio (OR)=3.268, 95% confidence interval (95%CI) was 1.196-8.927, P=0.021], septic shock at bloodstream infection onset (OR=3.637, 95%CI was 1.293-10.235, P=0.014), and the need for mechanical ventilation (OR=4.111, 95%CI was 1.242-13.610, P=0.021) were independent risk factors for 3-month all-cause death in patients with bloodstream infection, while receipt of appropriate empirical antibiotic therapy after bloodstream infection onset was a protective factor (OR=0.316, 95%CI was 0.118-0.844, P=0.022). The Hosmer-Lemeshow test yielded a χ 2 value of 5.082 with 6 degrees of freedom (P=0.533), indicating no evidence of overfitting.
CONCLUSIONS: Bloodstream infection is a common complication among patients in the medical ICU, with Enterobacteriaceae being the most frequently isolated pathogens. The mortality of bloodstream infection is high. LYM≤0.5×109/L at bloodstream infection onset, septic shock at bloodstream infection onset, and the need for mechanical ventilation are independent risk factors for 3-month all-cause death in patients with bloodstream infection, while receipt of appropriate empirical antibiotic therapy after bloodstream infection onset is a protective factor.
参考来源
- Tang Y, Wang P, Long G, et al. [Risk factors of death in patients with bloodstream infections in a medical intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42563676. doi:10.3760/cma.j.cn121430-20260205-00076
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。